Fulltext

Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014

Ismail MD 1 , Jalalonmuhali M 2 , Azhari Z 3 , Mariapun J 4 , Lee ZV 3 , Zainal Abidin I 3 Show all authors , Wan Ahmad WA 3 , Zuhdi ASM 3 , NCVD-PCI investigators

Affiliations 

  • 1 Division of Cardiology, Department of Medicine, University Malaya Medical Centre, 59100, Kuala Lumpur, Malaysia. dzafir@ummc.edu.my
  • 2 Division of Nephrology, Department of Medicine, University Malaya Medical Centre, 59100, Kuala Lumpur, Malaysia
  • 3 Division of Cardiology, Department of Medicine, University Malaya Medical Centre, 59100, Kuala Lumpur, Malaysia
  • 4 Department of Social and Preventive Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia
BMC Cardiovasc Disord, 2018 09 24;18(1):184.
PMID: 30249197 DOI: 10.1186/s12872-018-0919-9

Abstract

BACKGROUND: Patients with renal impairment often left out from most major clinical trials assessing the optimal treatment for ST-elevation myocardial infarction (STEMI). Large body of evidence from various cardiovascular registries reflecting more 'real-world' experience might contribute to the knowledge on how best to treat this special cohort. We aim to analyze the outcomes of Malaysian STEMI patients with renal impairment treated with coronary angioplasty.

METHODS: Utilizing the Malaysian National Cardiovascular Disease Database-Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014, STEMI patients treated with percutaneous coronary intervention (PCI) were stratified into presence (GFR 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications